We attended the ASCO Annual Meeting from June 3-7, 2016 in Chicago. ASCO stands for the American Society of Clinical Oncology.
Its annual meeting is the biggest and most important oncology conference throughout the year. More than 30000 attendees got updates on clinical trials, evolving science and just about everything else around oncology. Immunooncology (IO) was the key theme at the conference with very promising developments. However, new therapies are also needed for patients not responding to IO treatments.